UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Donanemab removes Alzheimer's plaques: what is special about its target?

Alawode, Deborah OT; Heslegrave, Amanda J; Fox, Nick C; Zetterberg, Henrik; (2021) Donanemab removes Alzheimer's plaques: what is special about its target? The Lancet Healthy Longevity , 2 (7) e395-e396. 10.1016/S2666-7568(21)00144-6. Green open access

[thumbnail of Zetterberg_Donanemab removes Alzheimer's plaques_VoR.pdf]
Preview
 Text
Zetterberg_Donanemab removes Alzheimer's plaques_VoR.pdf - Published Version
Download (51kB) | Preview
Type: Article
Title: Donanemab removes Alzheimer's plaques: what is special about its target?
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/S2666-7568(21)00144-6
Publisher version: https://doi.org/10.1016/S2666-7568(21)00144-6
Language: English
Additional information: Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
Keywords: Humans, Alzheimer Disease, Antibodies, Monoclonal, Plaque, Amyloid, Plaque, Atherosclerotic
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/10156029
Downloads since deposit
14Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item